162 related articles for article (PubMed ID: 12665511)
21. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1.
Böhm R; Imseng S; Jakob RP; Hall MN; Maier T; Hiller S
Mol Cell; 2021 Jun; 81(11):2403-2416.e5. PubMed ID: 33852892
[TBL] [Abstract][Full Text] [Related]
22. Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1.
Wang L; Rhodes CJ; Lawrence JC
J Biol Chem; 2006 Aug; 281(34):24293-303. PubMed ID: 16798736
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes.
Kudchodkar SB; Yu Y; Maguire TG; Alwine JC
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14182-7. PubMed ID: 16959881
[TBL] [Abstract][Full Text] [Related]
24. Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies.
Mothe-Satney I; Brunn GJ; McMahon LP; Capaldo CT; Abraham RT; Lawrence JC
J Biol Chem; 2000 Oct; 275(43):33836-43. PubMed ID: 10942774
[TBL] [Abstract][Full Text] [Related]
25. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin.
McMahon LP; Choi KM; Lin TA; Abraham RT; Lawrence JC
Mol Cell Biol; 2002 Nov; 22(21):7428-38. PubMed ID: 12370290
[TBL] [Abstract][Full Text] [Related]
26. mTOR phosphorylated at S2448 binds to raptor and rictor.
Rosner M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2010 Jan; 38(1):223-8. PubMed ID: 19145465
[TBL] [Abstract][Full Text] [Related]
27. The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus.
Brunn GJ; Fadden P; Haystead TA; Lawrence JC
J Biol Chem; 1997 Dec; 272(51):32547-50. PubMed ID: 9405468
[TBL] [Abstract][Full Text] [Related]
28. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction.
Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH
J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the protein kinase activity of mTOR.
Lawrence JC; Lin TA; McMahon LP; Choi KM
Curr Top Microbiol Immunol; 2004; 279():199-213. PubMed ID: 14560959
[TBL] [Abstract][Full Text] [Related]
30. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
[TBL] [Abstract][Full Text] [Related]
31. PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation.
Lawrence JC; Fadden P; Haystead TA; Lin TA
Adv Enzyme Regul; 1997; 37():239-67. PubMed ID: 9381973
[TBL] [Abstract][Full Text] [Related]
32. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle.
Southgate RJ; Neill B; Prelovsek O; El-Osta A; Kamei Y; Miura S; Ezaki O; McLoughlin TJ; Zhang W; Unterman TG; Febbraio MA
J Biol Chem; 2007 Jul; 282(29):21176-86. PubMed ID: 17510058
[TBL] [Abstract][Full Text] [Related]
33. Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner.
Miloslavski R; Cohen E; Avraham A; Iluz Y; Hayouka Z; Kasir J; Mudhasani R; Jones SN; Cybulski N; Rüegg MA; Larsson O; Gandin V; Rajakumar A; Topisirovic I; Meyuhas O
J Mol Cell Biol; 2014 Jun; 6(3):255-66. PubMed ID: 24627160
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR.
Yang D; Brunn GJ; Lawrence JC
FEBS Lett; 1999 Jun; 453(3):387-90. PubMed ID: 10405182
[TBL] [Abstract][Full Text] [Related]
35. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway.
Scott PH; Brunn GJ; Kohn AD; Roth RA; Lawrence JC
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7772-7. PubMed ID: 9636226
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
[TBL] [Abstract][Full Text] [Related]
37. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
38. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
Fuchs BC; Finger RE; Onan MC; Bode BP
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
[TBL] [Abstract][Full Text] [Related]
39. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
40. Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex.
Sarbassov DD; Sabatini DM
J Biol Chem; 2005 Nov; 280(47):39505-9. PubMed ID: 16183647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
